Crossref journal-article
Elsevier BV
Pharmacology & Therapeutics (78)
Bibliography

Lee, J. C., Kassis, S., Kumar, S., Badger, A., & Adams, J. L. (1999). p38 Mitogen-Activated Protein Kinase Inhibitors— Mechanisms and Therapeutic Potentials. Pharmacology & Therapeutics, 82(2–3), 389–397.

Authors 5
  1. John C. Lee (first)
  2. Shouki Kassis (additional)
  3. Sanjay Kumar (additional)
  4. Alison Badger (additional)
  5. Jerry L. Adams (additional)
References 67 Referenced 289
  1. 10.1016/S0960-894X(98)00549-6 / Bioorg. Med. Chem. Lett. / Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition for hepatic cytochrome P450 enzymes by Adams (1998)
  2. {'key': '10.1016/S0163-7258(99)00008-X_BIB2', 'first-page': '1453', 'article-title': 'Pharmacological profile of SB 203580, a selective inhibitor of CSBP/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function', 'volume': '279', 'author': 'Badger', 'year': '1996', 'journal-title': 'J. Pharmacol. Exp. Ther.'} / J. Pharmacol. Exp. Ther. / Pharmacological profile of SB 203580, a selective inhibitor of CSBP/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function by Badger (1996)
  3. 10.4049/jimmunol.161.1.467 / J. Immunol. / SB 203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes by Badger (1998)
  4. 10.1016/S0960-9822(98)70442-7 / Curr. Biol. / Nuclear export of the stress-activated protein kinase p38 mediated its substrate MAPKAP kinase-2 by Ben-Levy (1998)
  5. 10.1021/jm960415o / J. Med. Chem. / 1-Substituted 4-aryl-5-pyridinylimidazoles—a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency by Boehm (1996)
  6. 10.1021/bi00050a024 / Biochemistry / Kinetic mechanisms of the forward and reverse pp60c-src tyrosine kinase reactions by Boemer (1995)
  7. 10.1074/jbc.270.25.14843 / J. Biol. Chem. / How MAP kinases are regulated by Cobb (1995)
  8. 10.1021/bi00266a011 / Biochemistry / Adenosine cyclic 3′-5′-monophosphate dependent protein kinase by Cook (1982)
  9. 10.1016/0014-5793(95)00357-F / FEBS Lett. / SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1 by Cuenda (1995)
  10. 10.1093/emboj/16.2.295 / EMBO J. / Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and other cellular stresses is mediated by SAPKK3 (MKK6), comparison of the specificities of SAPK3 and SAPK2 (RK/p38) by Cuenda (1997)
  11. 10.1093/emboj/17.15.4426 / EMBO J. / Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB by Deak (1998)
  12. 10.1016/S0960-894X(98)00495-8 / Bioorg. Med. Chem. Lett. / Pyrroles and other heterocyles as inhibitor of p38 kinase by de Laszlo (1998)
  13. 10.1016/0092-8674(94)90380-8 / Cell / JNK1 by Derijard (1994)
  14. 10.1126/science.7839144 / Science / Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms by Derijard (1995)
  15. 10.1074/jbc.273.3.1741 / J. Biol. Chem. / Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6 by Enslen (1998)
  16. 10.1016/S1074-5521(98)90170-3 / Chem. Biol. / Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution by Eyers (1998)
  17. 10.1021/bi980832y / Biochemistry / The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition of pyridinylimidazole inhibitor binding by Frantz (1998)
  18. 10.1016/0092-8674(94)90278-X / Cell / Interleukin-l activates a novel protein kinase cascade that results in the phosphorylation of Hsp27 by Freshney (1994)
  19. 10.1093/emboj/16.8.1921 / EMBO J. / MNK1 by Fukunaga (1997)
  20. 10.1016/S0968-0896(96)00212-X / Bioorg. Med. Chem. / Regulation of stress-induced cytokine production by pyridinylimidazoles by Gallagher (1997)
  21. 10.1038/358414a0 / Nature / Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter by Gille (1992)
  22. 10.1093/emboj/16.12.3563 / EMBO J. / Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6)—comparison of its substrate specificity with that of other SAP kinases by Goedert (1997)
  23. 10.1074/jbc.273.25.15605 / J. Biol. Chem. / Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket by Gum (1998)
  24. 10.1126/science.7914033 / Science / A MAP kinase targeted by endotoxin and in mammalian cells by Han (1994)
  25. 10.1074/jbc.271.6.2886 / J. Biol. Chem. / Characterization of the structure and function of a novel MAP kinase kinase (MKK6) by Han (1996)
  26. 10.1038/386296a0 / Nature / Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation by Han (1997)
  27. 10.1016/0076-6879(91)00126-H / Methods Enzymol. / Protein kinase catalytic domain sequence database by Hanks (1991)
  28. 10.1517/13543776.7.7.729 / Expert Opin. Ther. Patents / Inhibitors of p38 kinase by Hanson (1997)
  29. 10.1021/jm980497b / J. Med. Chem. / 6-Amino-2-(4-fluorophenyl)-4-methoxy-3-(4-pyridyl)-1H-pyrrolo[2,3-b]pyridine (RWJ 68354) by Henry (1998)
  30. {'key': '10.1016/S0163-7258(99)00008-X_BIB30', 'first-page': '687', 'article-title': 'Pharmacological effects of SB 220025, a selective inhibitor of p38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models', 'volume': '284', 'author': 'Jackson', 'year': '1998', 'journal-title': 'J. Pharmacol. Exp. Ther.'} / J. Pharmacol. Exp. Ther. / Pharmacological effects of SB 220025, a selective inhibitor of p38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models by Jackson (1998)
  31. 10.1074/jbc.272.48.30122 / J. Biol. Chem. / Characterization of the structure and function of the fourth member of p38 group of mitogen-activated protein kinases by Jiang (1997)
  32. 10.1042/bj3020897 / Biochem. J. / Interleukin-1 activates a novel protein kinase that phosphorylates the epidermal-growth-factor receptor peptide T669 by Kracht (1994)
  33. 10.1074/jbc.270.49.29043 / J. Biol. Chem. / Human mitogen-activated protein kinase CSBP1, but not CSBP2, complements a hog1 deletion in yeast by Kumar (1995)
  34. 10.1006/bbrc.1997.6849 / Biochem. Biophys. Res. Commun. / Novel homologues of CSBP/p38 MAP kinase by Kumar (1997)
  35. 10.1038/369156a0 / Nature / The stress activated protein kinase subfamily of c-Jun kinases by Kyriakis (1994)
  36. 10.1002/jlb.59.2.152 / J. Leukocyte Biol. / Role of CSBP/p38/RK stress response kinase in LPS and cytokine signaling mechanisms by Lee (1996)
  37. 10.1016/0192-0561(88)90007-0 / Int. J. Immunopharmacol. / Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002 by Lee (1988)
  38. 10.1007/BF01972796 / Agents Actions / Effect of SK&F 86002 on cytokine production by human monocytes by Lee (1989)
  39. {'key': '10.1016/S0163-7258(99)00008-X_BIB39', 'article-title': 'Inhibition of human monocyte IL-1 production by SK&F 86002', 'volume': '1–12', 'author': 'Lee', 'year': '1990', 'journal-title': 'Int. J. Immunother. VI:'} / Int. J. Immunother. VI: / Inhibition of human monocyte IL-1 production by SK&F 86002 by Lee (1990)
  40. 10.1111/j.1749-6632.1993.tb17149.x / Ann. NY Acad. Sci. / Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors by Lee (1993)
  41. 10.1038/372739a0 / Nature / A protein kinase involved in the regulation of inflammatory cytokine biosynthesis by Lee (1994)
  42. 10.1006/bbrc.1996.1662 / Biochem. Biophys. Res. Commun. / The primary structure of p38-gamma—a new member of p38 group of MAP kinases by Li (1996)
  43. 10.1126/science.7716521 / Science / Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2 by Lin (1995)
  44. 10.1021/bi9706778 / Biochemistry / Kinetic mechanism for p38 MAP kinase by LoGrasso (1997)
  45. 10.1074/jbc.271.14.8488 / J. Biol. Chem. / Identification of MAPKAP kinase-3, a novel substrate of CSBP/p38 MAP kinase by McLaughlin (1996)
  46. 10.1016/0014-5793(96)00255-4 / FEBS Lett. / SAP kinase-3, a new member of the family of mammalian stress-activated protein kinases by Mertens (1996)
  47. 10.1093/emboj/17.12.3372 / EMBO J. / PRAK, a novel protein kinase regulated by the p38 MAP kinase by New (1998)
  48. 10.1006/bbrc.1998.9250 / Biochem. Biophys. Res. Commun. / Identification of stathmin as a novel substrate for p38 delta by Parker (1998)
  49. 10.1016/S0021-9258(19)36734-1 / J. Biol. Chem. / Kinetic model of the epidermal growth factor (EGF) receptor tyrosine kinase and a possible mechanism of its activation by EGF by Posner (1992)
  50. 10.1002/(SICI)1097-4644(19980615)69:4<436::AID-JCB5>3.0.CO;2-O / J. Cell. Biochem. / Analysis of the role of Hsp25 phosphorylation reveals the importance of the oligomerization state of this small heat shock protein in its protective function against TNFalpha- and hydrogen peroxide-induced cell death by Preville (1998)
  51. 10.1074/jbc.270.13.7420 / J. Biol. Chem. / Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine by Raingeaud (1995)
  52. 10.1128/MCB.16.3.1247 / Mol. Cell. Biol. / MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway by Raingeaud (1996)
  53. 10.1016/0092-8674(94)90277-1 / Cell / Identification of a novel protein kinase cascade stimulated by chemical stress and heat shock which activates MAP kinase-activated protein MAPKAP kinase-2 and induces phosphorylation of the small heat shock proteins by Rouse (1994)
  54. 10.1038/372794a0 / Nature / Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-jun by Sanchez (1994)
  55. 10.1074/jbc.272.31.19509 / J. Biol. Chem. / p38-2, a novel mitogen-activated protein kinase with distinct properties by Stein (1997)
  56. 10.1038/nsb0497-311 / Nature Struct. Biol. / A highly specific inhibitor of human p38 HAP kinase binds in the ATP pocket by Tong (1997)
  57. 10.1016/8756-3282(94)90277-1 / Bone / Cytokine suppressive antiinflammatory compounds inhibit bone resorption in vitro by Votta (1994)
  58. 10.1074/jbc.273.16.9373 / J. Biol. Chem. / The phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol esters, cell stresses, and cytokines is mediated by distinct MAP kinase pathways by Wang (1998)
  59. 10.1126/science.272.5266.1347 / Science / Stress-induced phosphorylation and activation of the transcription factor CHOP (GADDl53) by p38 HAP kinase by Wang (1996)
  60. 10.1073/pnas.94.6.2327 / Proc. Natl. Acad. Sci. / The structure of mitogen activated protein kinase p38 at 2.1 Å resolution by Wang (1997)
  61. 10.1016/S0969-2126(98)00113-0 / Structure / Structural basis of inhibitor selectivity in MAP kinases by Wang (1998)
  62. 10.1093/emboj/16.8.1909 / EMBO J. / Mitogen-activated protein kinases activate the serine/threonine kinases MNK1 and MNK2 by Waskiewicz (1997)
  63. 10.1016/0092-8674(95)90435-2 / Cell / Identification of a signal for rapid export of proteins from the nucleus by Wen (1995)
  64. 10.1074/jbc.271.44.27696 / J. Biol. Chem. / Crystal structure of p38 mitogen-activated protein kinase by Wilson (1996)
  65. 10.1016/S1074-5521(97)90194-0 / Chem. Biol. / The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase by Wilson (1997)
  66. 10.1007/BF01972723 / Agents Actions / Bicyclic imidazoles inhibit IL-1 and TNF production at the protein level by Young (1993)
  67. 10.1074/jbc.272.18.12116 / J. Biol. Chem. / Pyridinyl imidazole inhibitors of p38 MAP kinase bind in the ATP site by Young (1997)
Dates
Type When
Created 23 years, 1 month ago (July 25, 2002, 9:55 a.m.)
Deposited 2 years, 4 months ago (April 8, 2023, 7:02 p.m.)
Indexed 4 weeks ago (Aug. 2, 2025, 12:38 a.m.)
Issued 26 years, 3 months ago (May 1, 1999)
Published 26 years, 3 months ago (May 1, 1999)
Published Print 26 years, 3 months ago (May 1, 1999)
Funders 0

None

@article{Lee_1999, title={p38 Mitogen-Activated Protein Kinase Inhibitors— Mechanisms and Therapeutic Potentials}, volume={82}, ISSN={0163-7258}, url={http://dx.doi.org/10.1016/s0163-7258(99)00008-x}, DOI={10.1016/s0163-7258(99)00008-x}, number={2–3}, journal={Pharmacology &amp; Therapeutics}, publisher={Elsevier BV}, author={Lee, John C. and Kassis, Shouki and Kumar, Sanjay and Badger, Alison and Adams, Jerry L.}, year={1999}, month=may, pages={389–397} }